SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-21-005279
Filing Date
2021-11-17
Accepted
2021-11-17 20:02:11
Documents
2
Period of Report
2021-11-15

Document Format Files

Seq Description Document Type Size
1 form3-11172021_051144.html 3  
1 form3-11172021_051144.xml 3 1759
2 ex24-11172021_051144.htm EX-24 7543
  Complete submission text file 0001415889-21-005279.txt   10683
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KALA PHARMACEUTICALS, INC. 490 ARSENAL WAY, SUITE 120 WATERTOWN MA 02472
Business Address
Kharabi Darius (Reporting) CIK: 0001893729 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38150 | Film No.: 211422241